본문 바로가기
KERD
논문KCI 등재

Ganodermanontriol Suppresses the Progression of Lung Adenocarcinoma by Activating CES2 to Enhance the Metabolism of Mycophenolate Mofetil

2

조회

0

다운로드

0

인용

0

참고문헌

키워드

주제분류생물학

초록

New anti-lung cancer therapies are urgently required to improve clinical outcomes. Since ganodermanontriol (GDNT) has been identified as a potential antineoplastic agent, its role in lung adenocarcinoma (LUAD) is investigated in this study. Concretely, lung cancer cells were treated with GDNT and/or mycophenolate mofetil (MMF), after which MTT assay, flow cytometry and Western blot were conducted. Following bioinformatics analysis, carboxylesterase 2 (CES2) was knocked down and rescue assays were carried out in vitro. Xenograft experiment was performed on mice, followed by drug administration, measurement of tumor growth and determination of CES2, IMPDH1 and IMPDH2 expressions. As a result, the viability of lung cancer cells was reduced by GDNT or MMF. GDNT enhanced the effects of MMF on suppressing viability, promoting apoptosis and inducing cell cycle arrest in lung cancer cells. GDNT up-regulated CES2 level, and strengthened the effects of MMF on down-regulating IMPDH1 and IMPDH2 levels in the cells. IMPDH1 and IMPDH2 were highly expressed in LUAD samples. CES2 was a potential target for GDNT. CES2 knockdown reversed the synergistic effect of GDNT and MMF against lung cancer in vitro. GDNT potentiated the role of MMF in inhibiting tumor growth and expressions of CES2 and IMPDH1/2 in lung cancer in vivo. Collectively, GDNT suppresses the progression of LUAD by activating CES2 to enhance the metabolism of MMF.

Abstract

New anti-lung cancer therapies are urgently required to improve clinical outcomes. Since ganodermanontriol (GDNT) has been identified as a potential antineoplastic agent, its role in lung adenocarcinoma (LUAD) is investigated in this study. Concretely, lung cancer cells were treated with GDNT and/or mycophenolate mofetil (MMF), after which MTT assay, flow cytometry and Western blot were conducted. Following bioinformatics analysis, carboxylesterase 2 (CES2) was knocked down and rescue assays were carried out in vitro. Xenograft experiment was performed on mice, followed by drug administration, measurement of tumor growth and determination of CES2, IMPDH1 and IMPDH2 expressions. As a result, the viability of lung cancer cells was reduced by GDNT or MMF. GDNT enhanced the effects of MMF on suppressing viability, promoting apoptosis and inducing cell cycle arrest in lung cancer cells. GDNT up-regulated CES2 level, and strengthened the effects of MMF on down-regulating IMPDH1 and IMPDH2 levels in the cells. IMPDH1 and IMPDH2 were highly expressed in LUAD samples. CES2 was a potential target for GDNT. CES2 knockdown reversed the synergistic effect of GDNT and MMF against lung cancer in vitro. GDNT potentiated the role of MMF in inhibiting tumor growth and expressions of CES2 and IMPDH1/2 in lung cancer in vivo. Collectively, GDNT suppresses the progression of LUAD by activating CES2 to enhance the metabolism of MMF.

참고문헌 (49)

  1. Sung H, "Global Cancer Statistics 2020 : GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries", CA : Cancer J. Clin, 71, pp.209~249 (2021)
  2. Herbst RS, "The biology and management of non-small cell lung cancer", Nature, 553, pp.446~454 (2018)
  3. Luo C, "Systematic construction and validation of an immune prognostic model for lung adenocarcinoma", J. Cell. Mol. Med, 24, pp.1233~1244 (2020)
  4. Nooreldeen R, "Current and future development in lung cancer diagnosis", Int. J. Mol. Sci, 22, pp.8661~ (2021)
  5. Kadara H, "Early events in the molecular pathogenesis of lung cancer", Cancer Prev. Res, 9, pp.518~527 (2016)
  6. Duma N, "Non-small cell lung cancer : epidemiology, screening, diagnosis, and treatment", Mayo Clin. Proc, 94, pp.1623~1640 (2019)
  7. Soccol CR, "Pharmacological properties of biocompounds from spores of the lingzhi or reishi medicinal mushroom Ganoderma lucidum(Agaricomycetes) : a review", Int. J. Med. Mushrooms, 18, pp.757~767 (2016)
  8. Chan SW, "The beneficial effects of Ganoderma lucidum on cardiovascular and metabolic disease risk", Pharm. Biol, 59, pp.1161~1171 (2021)
  9. Sohretoglu D, "Ganoderma lucidum polysaccharides as an anti-cancer agent", Anticancer Agents Med. Chem, 18, pp.667~674 (2018)
  10. Shao Y, "Structure identification and anti-cancer pharmacological prediction of triterpenes from Ganoderma lucidum", Molecules, 21, pp.678~ (2016)
  11. Barbieri A, "Anticancer and anti-inflammatory properties of Ganoderma lucidum extract effects on melanoma and triple-negative breast cancer treatment", Nutrients, 9, pp.210~ (2017)
  12. Liu W, "Ganoderma triterpenoids attenuate tumour angiogenesis in lung cancer tumour-bearing nude mice", Pharm. Biol, 58, pp.1061~1068 (2020)
  13. Zhu J, "Improved antitumor activity of cisplatin combined with Ganoderma lucidum polysaccharides in U14 cervical carcinoma-bearing mice", Kaohsiung J. Med. Sci, 35, pp.222~229 (2019)
  14. Li X, "Characterizing novel anti-oncogenic triterpenoids from ganoderma", Cell Cycle, 17, pp.527~528 (2018)
  15. Jiang J, "Ganodermanontriol(GDNT)exerts its effect on growth and invasiveness of breast cancer cells through the down-regulation of CDC20 and uPA", Biochem. Biophys. Res. Commun, 415, pp.325~329 (2011)
  16. Jedinak A, "Ganodermanontriol, a lanostanoid triterpene from Ganoderma lucidum, suppresses growth of colon cancer cells through ß-catenin signaling", Int. J. Oncol, 38, pp.761~767 (2011)
  17. Xu C, "Ganodermanontriol inhibits expression of special AT rich sequence binding protein 1gene in human hepatocellular carcinoma", J. Cancer Res. Ther, 14, pp.S964~s968 (2018)
  18. Zou LW, "Carboxylesterase inhibitors : an update", Curr. Med. Chem, 25, pp.1627~1649 (2018)
  19. Chen F, "Clinical implications of genetic variation in carboxylesterase drug metabolism", Exp. Opin. Drug Metab. Txicol, 14, pp.131~142 (2018)
  20. Lam SW, "Single-nucleotide polymorphisms in the genes of CES2, CDA and enzymatic activity of CDA for prediction of the efficacy of capecitabine-containing chemotherapy in patients with metastatic breast cancer", Pharm. Res, 128, pp.122~129 (2018)
  21. Zhang Y, "Overexpressed CES2 has prognostic value in CRC and knockdown CES2reverses L-OHP-resistance in CRC cells by inhibition of the PI3K signaling pathway", Exp. Cell Res, 389, pp.111856~ (2020)
  22. Cilião HL, "Polymorphisms in IMPDH2, UGT2B7, and CES2 genes influence the risk of graft rejection in kidney transplant recipients taking mycophenolate mofetil", Mutat. Res. Genet. Toxicol. Environ. Mutagen, 836, pp.97~102 (2018)
  23. Parlakpinar H, "Transplantation and immunosuppression : a review of novel transplant-related immunosuppressant drugs", Immunopharmacol. Immunotoxicol, 43, pp.651~665 (2021)
  24. Chen X, "The HNF4α-BC200-FMR1-positive feedback loop promotes growth and metastasis in invasive mucinous lung adenocarcinoma", Cancer Res, 81, pp.5904~5918 (2021)
  25. Naffouje R, "Anti-tumor potential of IMP dehydrogenase inhibitors : a century-long story", Cancers, 11, pp.1346~ (2019)
  26. Keppeke GD, "IMPDH-based cytoophidium structures as potential theranostics in cancer", Mol. Ther, 28, pp.1557~1558 (2020)
  27. Stracke S, "Antiproliferative and overadditive effects of everolimus and mycophenolate mofetil in pancreas and lung cancer cells in vitro", Transplant. Proc, 38, pp.766~770 (2006)
  28. Chandrashekar DS, "UALCAN : a portal for facilitating tumor subgroup gene expression and survival analyses", Neoplasia, 19, pp.649~658 (2017)
  29. Daina A, "SwissTargetPrediction : updated data and new features for efficient prediction of protein targets of small molecules", Nucleic Acids Res, 47, pp.W357~w364 (2019)
  30. Livak KJ, "Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T))method", Methods, 25, pp.402~408 (2001)
  31. Yang Z, "Nanoparticle formulation of mycophenolate mofetil achieves enhanced efficacy against hepatocellular carcinoma by targeting tumour-associated fibroblast", J. Cell. Mol. Med, 25, pp.3511~3523 (2021)
  32. Kennedy EM, "Semisynthesis and biological evaluation of ganodermanontriol and its stereoisomeric triols", J. Nat. Prod, 74, pp.2332~2337 (2011)
  33. Wang M, "Toward personalized treatment approaches for non-small-cell lung cancer", Nat. Med, 27, pp.1345~1356 (2021)
  34. Guo J, "Ganoderma lucidum-derived polysaccharide enhances coix oil-based microemulsion on stability and lung cancer-targeted therapy", Drug Deliv, 25, pp.1802~1810 (2018)
  35. Feng L, "Anti-lung cancer activity through enhancement of immunomodulation and induction of cell apoptosis of total triterpenes extracted from Ganoderma luncidum (Leyss. ex Fr.) Karst", Molecules, 18, pp.9966~9981 (2013)
  36. Zolj S, "Antiproliferative effects of a rriterpene-enriched extract from lingzhi or reishi medicinal mushroom, Ganoderma lucidum(Agaricomycetes), on human lung cancer cells", Int. J. Med. Mushrooms, 20, pp.1173~1183 (2018)
  37. Wang T, "Total triterpenoids from Ganoderma Lucidum suppresses prostate cancer cell growth by inducing growth arrest and apoptosis", J. Huazhong Univ. Sci. Technol. Med. Sci, 35, pp.736~741 (2015)
  38. Wang H, "NUSAP1 accelerates osteosarcoma cell proliferation and cell cycle progression via upregulating CDC20 and cyclin A2", OncoTargets Ther, 14, pp.3443~3454 (2021)
  39. Chu Z, "CDC20 contributes to the development of human cutaneous squamous cell carcinoma through the Wnt", β-catenin signaling pathway, 2019, pp.54, 1534~1544
  40. Hu H, "microRNA-1321 and microRNA-7515 contribute to the progression of non-small cell lung cancer by targeting CDC20", Kaohsiung J. Med. Sci, 38, pp.425~436 (2022)
  41. Plunk MA, "Design and catalyzed activation of mycophenolic acid prodrugs", ACS Med. Chem. Lett, 12, pp.812~816 (2021)
  42. Ling G, "Mycophenolate mofetil alone and in combination with tacrolimus inhibits the proliferation of HT-29 human colonic adenocarcinoma cell line and might interfere with colonic tumorigenesis", Anticancer Res, 38, pp.3333~3339 (2018)
  43. Silvestris N, "CES2, ABCG2, TS and Topo-I primary and synchronous metastasis expression and clinical outcome in metastatic colorectal cancer patients treated with first-line FOLFIRI regimen", Int. J. Mol. Sci, 15, pp.15767~15777 (2014)
  44. Winnicki W, "Individualization of mycophenolic acid therapy through pharmacogenetic, pharmacokinetic and pharmacodynamic testing", Biomedicines, 10, pp.2882~ (2022)
  45. Siebert A, "Anticancer properties of amino acid and peptide derivatives of mycophenolic acid", Antcancer Agents Med. Chem, 21, pp.462~467 (2021)
  46. Keppeke GD, "IMP", GTP balance modulates cytoophidium assembly and IMPDH activity, 2018, pp.13, 5~
  47. Valvezan AJ, "IMPDH inhibitors for antitumor therapy in tuberous sclerosis complex", JCI Insight, 5, pp.e135071~ (2020)
  48. Huang F, "Inosine monophosphate dehydrogenase dependence in a subset of small cell lung cancers", Cell Metab, 28, pp.369~382 (2018)
  49. Ruan H, "IMPDH1", YB-1 positive feedback loop assembles cytoophidia and represents a therapeutic target in metastatic tumors, 2020, pp.28, 1299~1313

관련 논문AI추천

Sanghuangporus sanghuang extract inhibits the proliferation and invasion of lung cancer cells in vitro and in vivoChen Guanping, Lu Na, Song Jiling, Wang Weike, Yan Jing한국영양학회 · Nutrition Research and Practice2023 · 제17권 제6호Comparative Multi-Omics Analysis and Antitumor Activity of Phylloporia crataegi and Phylloporia fontanesiaeFu Yan, Guo Zhihao, Tian Xuemei, Zhang Guoli, Zhang Yinghao, Zhang Yuyue한국미생물·생명공학회 · Journal of Microbiology and Biotechnology2025 · 제35권 Celastrol inhibits gastric cancer growth by induction of apoptosis and autophagy이현우, 전경희, 정재호, 조아라, 최혜지, Kenny Seung Bin Jang생화학분자생물학회 · BMB Reports2014 · 제47권 제12호Targeting CD73 to Overcomes Resistance to First-Generation EGFR Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancer김동완, 김미소, 김범석, 김소연, 김태민, 임지민, 전윤경, 허대석대한암학회 · Cancer Research and Treatment2023 · 제55권 제4호Differential Expression of Gene Profiles in MRGX -treated Lung Cancer성정석, 유화승, 이연월, 장익순, 조종관, Hwan-Soo Kang, Jong-Soon Choi, Seungjin Shin, Seung-Yeul Lee, Yong-Kyun Kwon대한약침학회 · Journal of Pharmacopuncture2013 · 제16권 제3호Anti-cancer Effect of Hot Water Extract from Mycelium in Germanium-enriched Cordyceps militaris김대진, 김성욱, 이민우, 이태복, 최정수, 허지혜, 남궁수민대한임상검사과학회 · 대한임상검사과학회지2017 · 제49권 제2호

이 간행물의 다른 논문 (25건)